Does MOLSIDOMINE Cause Cholecystitis? 36 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Cholecystitis have been filed in association with MOLSIDOMINE. This represents 9.4% of all adverse event reports for MOLSIDOMINE.
36
Reports of Cholecystitis with MOLSIDOMINE
9.4%
of all MOLSIDOMINE reports
36
Deaths
35
Hospitalizations
How Dangerous Is Cholecystitis From MOLSIDOMINE?
Of the 36 reports, 36 (100.0%) resulted in death, 35 (97.2%) required hospitalization, and 30 (83.3%) were considered life-threatening.
Is Cholecystitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Electrolyte imbalance (36)
Hyperthyroidism (36)
What Other Drugs Cause Cholecystitis?
LENVATINIB (309)
SEMAGLUTIDE (293)
PEMBROLIZUMAB (245)
ADALIMUMAB (234)
METHOTREXATE (205)
NIVOLUMAB (183)
RITUXIMAB (159)
LENALIDOMIDE (144)
BEVACIZUMAB (131)
CYCLOPHOSPHAMIDE (131)
Which MOLSIDOMINE Alternatives Have Lower Cholecystitis Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL